Rita Balice-Gordon

Rita Balice-Gordon

Director/Board Member at COLLEGIUM PHARMACEUTICAL, INC.

Net worth: 1 M $ as of 2024-02-28

63 year
Consumer Services
Health Technology
Retail Trade

Profile

Currently, Rita Balice-Gordon is Chief Executive Officer & Director at Muna Therapeutics ApS.
She is also on the board of Collegium Pharmaceutical, Inc. and Capsida Biotherapeutics, Inc. In her past career she held the position of President-Neuroscience & Pain Research Unit at Pfizer Inc., Global Head-Rare & Neurological Diseases at Sanofi, Inc. and Professor at Perelman School of Medicine.
She received an undergraduate degree from Northwestern University and a doctorate from The University of Texas at Austin.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-05-17 38,795 ( 0.12% ) 1 M $ 2024-02-28

Rita Balice-Gordon active positions

CompaniesPositionStart
COLLEGIUM PHARMACEUTICAL, INC. Director/Board Member 2020-09-23
Chief Executive Officer -
Director/Board Member 2021-05-11
All active positions of Rita Balice-Gordon

Former positions of Rita Balice-Gordon

CompaniesPositionEnd
PFIZER, INC. Corporate Officer/Principal -
Perelman School of Medicine Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Rita Balice-Gordon's experience

Training of Rita Balice-Gordon

Northwestern University Undergraduate Degree
The University of Texas at Austin Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Rita Balice-Gordon's experience

Connections

45

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
PFIZER, INC.

Health Technology

COLLEGIUM PHARMACEUTICAL, INC.

Health Technology

Private companies3

Retail Trade

Health Services

Commercial Services

See company connections
  1. Stock
  2. Insiders
  3. Rita Balice-Gordon